Manufacturer record
Ridley Life Science Pvt. Ltd: regulatory record
Last checked 20 September 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
26 batches manufactured by Ridley Life Science Pvt. Ltd (Delhi) were declared Not of Standard Quality between March 2019 and June 2024. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Records by type
26 records linked to Ridley Life Science Pvt. Ltd in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Norfloxacin Oral Suspension (Ridnor Suspension) | RL230022Mfg 2023-03 · Exp 2025-02 | Description and Total Fungal CountDescription | RDTL ChandigarhCDSCO lab | Jun 2024 |
| Cloxacillin Sodium Oral Suspension USP 125mg/5ml | RD220020Mfg 2022-07 · Exp 2024-06 | Assay of Cloxacillin Sodium calculated as CloxacillinAssay | RDTL ChandigarhCDSCO lab | Apr 2024 |
| Amoxycillin Oral Suspension IP | RD220034Mfg 2022-10 · Exp 2024-09 | Assay/Content of AmoxycillinAssay | RDTL GuwahatiCDSCO lab | Apr 2024 |
| Serratiopeptidase Tablets IP 10 mg (Serrarid-10) | RT220358Mfg 2022-04 · Exp 2024-03 | Disintegration & DescriptionDescription | RDTL GuwahatiState lab | Feb 2024 |
| Pheniramine Maleate Tablet IP (APVIL) | RT220512Mfg 2022-06 · Exp 2025-05 | DescriptionDescription | RDTL GuwahatiState lab | Feb 2024 |
| Pheniramine Maleate Tablet I.P. (APVIL) | RT220422Mfg 2022-05 · Exp 2025-04 | DescriptionDescription | RDTL GuwahatiState lab | Feb 2024 |
| Cefixime Oral Suspension IP 50mg/5ml | RD230004Mfg 2023-01 · Exp 2024-12 | Assay of CefiximeAssay | RDTL GuwahatiState lab | Jan 2024 |
| Cefixime Oral Suspension IP 50mg/5ml | RD230003Mfg 2023-01 · Exp 2024-12 | Assay of CefiximeAssay | RDTL GuwahatiState lab | Jan 2024 |
| Lycopene, Vitamin A, Vitamine E, Ascorbic Acid, Zinc Sulphate, Copper Sulphate, Manganese Sulphate, Beta Carotene & Sodium Selenate Capsules | RC220065Mfg 2022-11 · Exp 2024-04 | DescriptionDescription | RDTL GuwahatiState lab | Dec 2023 |
| AMOXYCILLIN ORAL SUSPENSION I.P. 250 mg/5ml | RD220037Mfg 2022-10 · Exp 2024-09 | Assay & pHAssay | RDTL GuwahatiState lab | Dec 2023 |
| VITAMIN C TABLETS I.P. 500 mg.(XTRA-C), | XTR-2112Mfg 2021-10 · Exp 2025-09 | Uniformity of WeightUniformity of weight/content | RDTL GuwahatiCDSCO lab | Sep 2023 |
| Telmisartan Tablets IP 40 mg | RT230014Mfg 2023-01 · Exp 2024-12 | Dissolution and Assay of TelmisartanAssay | RDTL ChandigarhCDSCO lab | Sep 2023 |
| Isosorbide Mononitrate Tablets IP 20 mg | RT220347Mfg 2022-04 · Exp 2024-03 | Dissolution and Assay of Diluted Isosorbide Mononitrate Calculated as Isosorbide MononitrateAssay | RDTL ChandigarhCDSCO lab | Sep 2023 |
| Rabeprazole Sodium and Domperidone Tablets | RT220468Mfg 2022-05 · Exp 2024-04 | DescriptionDescription | RDTL GuwahatiState lab | May 2023 |
| APVIL (Pheniramine Maleate Tablets I.P.) | RT220155Mfg 2022-02 · Exp 2025-01 | Assay of Pheniramine MaleateAssay | CDL KolkataCDSCO lab | Mar 2023 |
| INDIFIBER (Fenofibrate Capsules I.P.) | 6078Mfg 2022-04 · Exp 2024-03 | DissolutionDissolution | CDTL MumbaiCDSCO lab | Jan 2023 |
| Omirid-10 (Omeprazole Capsules IP) | OMI-2101Mfg 2021-04 · Exp 2023-03 | DissolutionDissolution | RDTL GuwahatiState lab | Dec 2022 |
| Misoprostol Tablets I.P. 200 mcg | RT220304Mfg 2022-03 · Exp 2024-02 | AssayAssay | CDL KolkataCDSCO lab | Oct 2022 |
| Norfloxacin Tablets IP Ridnor-400 | RID-1925Mfg 2020-02 · Exp 2023-01 | DissolutionDissolution | RDTL GuwahatiState lab | Aug 2022 |
| Norfloxacin Tablets IP | NOR-2001Mfg 2021-01 · Exp 2022-12 | DissolutionDissolution | RDTL GuwahatiState lab | Aug 2022 |
| Cloxacillin Sodium Capsules IP 500 mg (CLOXRID-500 CAPSULES) | CLO-2003Mfg 2020-07 · Exp 2022-06 | IdentificationIdentification | RDTL ChandigarhCDSCO lab | May 2022 |
| Doxycycline Hydrochloride & Ambroxol HCl Tablets | DOX-2009Mfg 2021-01 · Exp 2022-12 | DescriptionDescription | RDTL GuwahatiState lab | Jan 2022 |
| Omeprazole Capsules IP | OMI-2001Mfg 2020-04 · Exp 2022-03 | Dissolution & LOD TestDissolution | RDTL GuwahatiCDSCO lab | Jun 2021 |
| GLUCORID (Metformin Hydrochloride Sustained Release Tablets I.P. 500 mg) | GLU-2009Mfg 2020-08 · Exp 2022-07 | DissolutionDissolution | CDL KolkataCDSCO lab | Apr 2021 |
| Cardirid (Carvedilol Tablets IP) | CAR-2001Mfg 2020-06 · Exp 2022-05 | Uniformity of Content and Related SubstancesUniformity of weight/content | CDL KolkataCDSCO lab | Feb 2021 |
| Azorid-250 (Azithromycin Tablets IP) | AZO-1801Mfg 2018-06 · Exp 2020-05 | AssayAssay | CDTL MumbaiCDSCO lab | Mar 2019 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.